CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −380,852 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +380,852 | 380,852 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −106,951 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +106,951 | 106,951 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −534,759 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +534,759 | 534,759 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −263,101 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +263,101 | 263,101 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −107,028 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +107,028 | 107,028 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −241,210 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +241,210 | 241,210 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −478,288 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +478,288 | 478,288 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Returned to the company · Stock Option (Right to Buy) | −245,989 | 0 | ||
| 2024-07-01 | Babler Martin President, CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +245,989 | 245,989 | ||
| 2024-06-27 | Yao Zhengbin Director | Grant or award · Stock Option (Right to Buy) | +31,016 | 31,016 | ||
| 2024-06-27 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +28,877 | 28,877 | ||
| 2024-06-27 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2024-06-27 | Richardson Derrick SVP, People and Culture | Grant or award · Stock Option (Right to Buy) | +3,208 | 3,208 |
Page 20 of 21 · 405 trades